Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Name: Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
SKU: 4537
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 3 Articles Tags: daniel-j-carlat, md, medworks-media, psychopharmacology, psychopharmacology-bulletin

Description

Description

Daniel J. Carlat, MD Link

COMMENTARY

Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Description

Daniel J. Carlat, MD Link

COMMENTARY

Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Daniel J. Carlat,MD

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

Antipsychotic Induced Symptomatic Hyperprolactinemia

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Description

Daniel J. Carlat, MD Link

COMMENTARY

Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Daniel J. Carlat,MD

Related products

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

Antipsychotic Induced Symptomatic Hyperprolactinemia

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan